BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33710780)

  • 1. Prognostic value of the geriatric nutritional risk index among patients with previously treated advanced non-small cell lung cancer who subsequently underwent immunotherapy.
    Sonehara K; Tateishi K; Araki T; Komatsu M; Yamamoto H; Hanaoka M
    Thorac Cancer; 2021 May; 12(9):1366-1372. PubMed ID: 33710780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy.
    Karayama M; Inoue Y; Yasui H; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suda T
    BMC Pulm Med; 2021 Dec; 21(1):409. PubMed ID: 34895201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Prognostic Model of Elderly Patients with Non-small Cell Lung Cancer 
Based on Geriatric Nutritional Risk Index].
    Zhang X; Xiong Y; Xu A
    Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):497-506. PubMed ID: 37653013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Geriatric Nutritional Risk Index: A predictive and prognostic factor in patients with pathological stage I non-small cell lung cancer.
    Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
    Surg Oncol; 2017 Dec; 26(4):483-488. PubMed ID: 29113668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Geriatric Nutritional Risk Index and Prognostic Nutritional Index Predict the Overall Survival of Advanced Non-Small Cell Lung Cancer Patients.
    Matsuura S; Morikawa K; Ito Y; Kubota T; Ichijo K; Mochizuki E; Akiyama N; Uehara M; Harada M; Tsukui M; Koshimizu N
    Nutr Cancer; 2022; 74(5):1606-1613. PubMed ID: 34431441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Geriatric Nutritional Risk Index as a Prognostic Factor in Patients with Advanced Non-Small-Cell Lung Cancer.
    Peng SM; Yu N; Ren JJ; Xu JY; Chen GC; Yang JR; Li ZN; Du HZ; Li DP; Zhang YS; Qin LQ
    Nutr Cancer; 2021; 73(11-12):2832-2841. PubMed ID: 33356605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
    Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive-stage disease small cell lung cancer: Results from a randomized controlled trial.
    Lee GW; Go SI; Kim DW; Kim HG; Kim JH; An HJ; Jang JS; Kim BS; Hahn S; Heo DS
    Thorac Cancer; 2020 Jan; 11(1):62-71. PubMed ID: 31707767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: a multicentre retrospective study.
    Shoji F; Miura N; Matsubara T; Akamine T; Kozuma Y; Haratake N; Takamori S; Katsura M; Takada K; Toyokawa G; Takenaka T; Yamazaki K; Okamoto T; Takeo S; Maehara Y
    Interact Cardiovasc Thorac Surg; 2018 Mar; 26(3):389-394. PubMed ID: 29049803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non-Small Cell Lung Cancer After Nivolumab Therapy.
    Karayama M; Inoue Y; Yoshimura K; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suda T
    J Immunother; 2022 Feb-Mar 01; 45(2):125-131. PubMed ID: 34653100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of nutritional and inflammatory markers in patients with hepatocellular carcinoma who receive immune checkpoint inhibitors.
    Liu C; Zhao H; Zhang R; Guo Z; Wang P; Qu Z
    Oncol Lett; 2023 Oct; 26(4):437. PubMed ID: 37664652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Immune-Related Adverse Events in Prognosis and Efficacy Prediction for Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy: A Retrospective Clinical Analysis.
    Sonehara K; Tateishi K; Araki T; Komatsu M; Yamamoto H; Koizumi T; Hanaoka M
    Oncology; 2021; 99(5):271-279. PubMed ID: 33631764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of circulating IgM and geriatric nutritional risk index predicts the prognostic of hepatocellular carcinoma patients who underwent immune checkpoint inhibitors.
    Liu C; Zhao H; Wang P; Guo Z; Qu Z
    Int Immunopharmacol; 2023 Oct; 123():110704. PubMed ID: 37506504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of survival among Japanese patients receiving first-line chemoimmunotherapy for advanced non-small cell lung cancer.
    Ogura Y; Kataoka N; Kunimatsu Y; Tachibana Y; Sugimoto T; Tani N; Sato I; Hirose K; Kato D; Takeda T
    Thorac Cancer; 2021 Jan; 12(1):97-105. PubMed ID: 33124197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer.
    Haas M; Lein A; Fuereder T; Brkic FF; Schnoell J; Liu DT; Kadletz-Wanke L; Heiduschka G; Jank BJ
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Geriatric Nutritional Risk Index With Immune Checkpoint Inhibitor Treatment Duration and Adverse Events in Lung Cancer.
    Shimizu A; Fukasawa M; Mitani K; Goto K; Wakamoto A; Hatsuyama T; Hoshi T; Hasegawa I; Sato H
    In Vivo; 2024; 38(1):418-424. PubMed ID: 38148096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported outcomes as a prognostic marker of survival in patients with advanced nonsmall cell lung cancer treated with immunotherapy.
    Hopkins AM; Wagner J; Kichenadasse G; Modi N; Rowland A; Sorich MJ
    Int J Cancer; 2020 Dec; 147(11):3085-3089. PubMed ID: 32492185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Geriatric Nutritional Risk Index as a Poor Prognostic Marker for Second-Line Pembrolizumab Treatment in Patients with Metastatic Urothelial Carcinoma: A Retrospective Multicenter Analysis.
    Etani T; Naiki T; Sugiyama Y; Nagai T; Iida K; Noda Y; Shimizu N; Tasaki Y; Mimura Y; Okada T; Banno R; Kubota H; Hamamoto S; Ando R; Kawai N; Yasui T
    Oncology; 2020; 98(12):876-883. PubMed ID: 32862183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geriatric nutritional risk index as an independent prognostic factor in locally advanced nasopharyngeal carcinoma treated using radical concurrent chemoradiotherapy: a retrospective cohort study.
    Tang QN; Qiu HZ; Sun XQ; Guo SS; Liu LT; Wen YF; Liu SL; Xie HJ; Liang YJ; Sun XS; Li XY; Yan JJ; Yang JH; Wen DX; Guo L; Tang LQ; Chen QY; Mai HQ
    Ann Transl Med; 2021 Apr; 9(7):532. PubMed ID: 33987230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-PLAN index as a prognostic factor for patients with previously untreated advanced non-small cell lung cancer who received combination immunotherapy: A multicenter retrospective study.
    Sonehara K; Ozawa R; Hama M; Nozawa S; Agatsuma T; Nishie K; Kato A; Matsuo A; Araki T; Komatsu M; Tateishi K; Hanaoka M
    Thorac Cancer; 2023 Feb; 14(6):636-642. PubMed ID: 36635979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.